{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:14:17Z","timestamp":1791476057709,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40744-024-00664-3","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:01:39Z","timestamp":1714046499000},"page":"795-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevating the Standard of Care for Patients with Psoriatic Arthritis: \u2018Calls to Action\u2019 from a Multistakeholder Pan-European Initiative"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3681-1628","authenticated-orcid":false,"given":"Iris","family":"Verbinnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5352-2601","authenticated-orcid":false,"given":"Emilio","family":"Monte-Boquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlev","family":"Parow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-4159","authenticated-orcid":false,"given":"Andrew","family":"Pothecary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno W. R.","family":"van Kuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edita","family":"M\u00fcllerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-1502","authenticated-orcid":false,"given":"Andreas","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3565-2410","authenticated-orcid":false,"given":"Ulrike","family":"Erstling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tomasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-9105","authenticated-orcid":false,"given":"Philip S.","family":"Helliwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"issue":"6s","key":"664_CR1","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.12788\/j.sder.2018.057","volume":"37","author":"EW Baum","year":"2018","unstructured":"Baum EW, Schwartzman S. ALIGN PsA: advancing a multidisciplinary approach in PsA. Semin Cutan Med Surg. 2018;37(6s):S125\u201334.","journal-title":"Semin Cutan Med Surg"},{"issue":"4","key":"664_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","volume":"41","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Weiss P. The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am. 2015;41(4):545\u201368.","journal-title":"Rheum Dis Clin North Am"},{"key":"664_CR3","doi-asserted-by":"crossref","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14\u20137.","DOI":"10.1136\/ard.2004.032482"},{"issue":"2","key":"664_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40744-017-0066-2","volume":"4","author":"M Garrido-Cumbrera","year":"2017","unstructured":"Garrido-Cumbrera M, Hillmann O, Mahapatra R, et al. Improving the management of psoriatic arthritis and axial spondyloarthritis: roundtable discussions with healthcare professionals and patients. Rheumatol Ther. 2017;4(2):219\u201331.","journal-title":"Rheumatol Ther"},{"key":"664_CR5","doi-asserted-by":"crossref","unstructured":"Haugeberg G, Michelsen B, Kavanaugh A. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: a cross-sectional study of outpatient clinic patients in the biologic treatment era. RMD Open. 2020;6(1):e001223.","DOI":"10.1136\/rmdopen-2020-001223"},{"issue":"10","key":"664_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957\u201370.","journal-title":"N Engl J Med"},{"issue":"5","key":"664_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/acr.22492","volume":"67","author":"SR Feldman","year":"2015","unstructured":"Feldman SR, Zhao Y, Shi L, Tran MH, Lu J. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Arthritis Care Res (Hoboken). 2015;67(5):708\u201317.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"664_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3899\/jrheum.170142","volume":"44","author":"G Favier","year":"2017","unstructured":"Favier G, Gladman DD, Merola JF, Armstrong AW, Boehncke WH, Helliwell PS. Benchmarking care in psoriatic arthritis\u2014the QUANTUM report: a report from the GRAPPA 2016 annual meeting. J Rheumatol. 2017;44(5):674\u20138.","journal-title":"J Rheumatol"},{"issue":"4","key":"664_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/jdv.13306","volume":"30","author":"N Betteridge","year":"2016","unstructured":"Betteridge N, Boehncke WH, Bundy C, Gossec L, Gratac\u00f3s J, Augustin M. Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience. J Eur Acad Dermatol Venereol. 2016;30(4):576\u201385.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"664_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","volume":"79","author":"L Gossec","year":"2020","unstructured":"Gossec L, Baraliakos X, Kerschbaumer A, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020;79(6):700\u201312.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"664_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13555-022-00846-3","volume":"13","author":"J Koren","year":"2023","unstructured":"Koren J, Lambert JLW, Thomsen SF, McAteer H, Fabbrocini G, Corazza V, et al. Elevating the standard of care for patients with psoriasis: \u201ccalls to action\u201d from epicensus, a multistakeholder pan-European initiative. Dermatol Ther (Heidelb). 2023;13(1):245\u201368.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"664_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.reuma.2014.01.004","volume":"10","author":"J Luelmo","year":"2014","unstructured":"Luelmo J, Gratac\u00f3s J, Moreno Mart\u00ednez-Losa M, et al. A report of 4\u00a0years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis. Reumatol Clin. 2014;10(3):141\u20136.","journal-title":"Reumatol Clin"},{"key":"664_CR13","doi-asserted-by":"crossref","unstructured":"Sacrist\u00e1n JA, Dilla T, D\u00edaz-Cerezo S, Gab\u00e1s-Rivera C, Aceituno S, Liz\u00e1n L. Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature. PLoS One. 2020;15(6):e0234705.","DOI":"10.1371\/journal.pone.0234705"},{"issue":"9","key":"664_CR14","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s10067-017-3578-9","volume":"36","author":"DE Furst","year":"2017","unstructured":"Furst DE, Tran M, Sullivan E, et al. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clin Rheumatol. 2017;36(9):2045\u201354.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"664_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/BOR.0000000000000801","volume":"33","author":"AO Adebajo","year":"2021","unstructured":"Adebajo AO, Akintayo RO. Patient educational needs and challenges in psoriatic arthritis. Curr Opin Rheumatol. 2021;33(4):356\u201362.","journal-title":"Curr Opin Rheumatol"},{"key":"664_CR16","doi-asserted-by":"crossref","unstructured":"van der Veen S, Evans N, Huisman M, Welch Saleeby P, Widdershoven G. Toward a paradigm shift in healthcare: using the international classification of functioning, disability and health (ICF) and the capability approach (CA) jointly in theory and practice. Disabil Rehabil. 2023:45(14):2382\u201389.","DOI":"10.1080\/09638288.2022.2089737"},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3899\/jrheum.190120","volume":"95","author":"PS Helliwell","year":"2019","unstructured":"Helliwell PS, Favier G, Gladman DD, et al. Best-practice indicators in psoriatic disease care. J Rheumatol Suppl. 2019;95:38\u201345.","journal-title":"J Rheumatol Suppl"},{"issue":"6","key":"664_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/ijpp.12076","volume":"21","author":"P Aslani","year":"2013","unstructured":"Aslani P. Patient empowerment and informed decision-making. Int J Pharm Pract. 2013;21(6):347\u20138.","journal-title":"Int J Pharm Pract"},{"key":"664_CR19","first-page":"284","volume":"240","author":"AH Krist","year":"2017","unstructured":"Krist AH, Tong ST, Aycock RA, Longo DR. Engaging patients in decision-making and behavior change to promote prevention. Stud Health Technol Inform. 2017;240:284\u2013302.","journal-title":"Stud Health Technol Inform"},{"key":"664_CR20","unstructured":"GRAPPA. GRAPPA Career Boost eLearning. Effective clinical communication for improved outcomes 2023. https:\/\/elearn.grappanetwork.org\/."},{"key":"664_CR21","doi-asserted-by":"publisher","unstructured":"Hackett S, Ogdie A, Coates LC. Psoriatic arthritis: prospects for the future. Therap Adv Musculosk Dis. 2022;14. https:\/\/doi.org\/10.1177\/1759720X2210867.","DOI":"10.1177\/1759720X2210867"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00664-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-024-00664-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00664-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:31:52Z","timestamp":1716391912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-024-00664-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s40744-024-00664-3","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Stakeholder leads (namely, Iris Verbinnen, Phillip S. Helliwell and Emilio Monte-Boquet) received an honorarium for their participation in the initial workshop and they and the other PsA CC members (Detlev Parow, Fabienne Lancombe, Andrew Pothecary, Arno W.R. van Kuijk, Edita M\u00fcllerov\u00e1, Andreas Pinter, Ulrike Erstling and Andrea Tomasini) received an honorarium from UCB for their time to complete the Delphi e-consultations and to attend the PsA CC meeting or provide their input offline. UCB Pharma reviewed the manuscript to ensure scientific and medical clarity and accuracy only. Emilio Monte-Boquet has received grants\/research support or participation in educational activities, research projects, scientific meetings (either attendance, speaking and\/or delivering presentations) and advisory boards sponsored by Abbott\/AbbVie, Amgen, Astellas, AstraZeneca, Baxalta, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Chiesi, CSL Behring, Eisai, Fresenius, Galapagos, Gilead, GSK, Ipsen, Janssen, Leo Pharma, Lilly, MSD, Merck-Serono, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Theramex, UCB and ViiV. Detlev Parow has received an honorarium for advisory boards from Boehringer-Ingelheim, Hexal and UCB. Iris Verbinnen, Ulrike Erstling, Andreas Pinter, Edita M\u00fcllerov\u00e1, Fabienne Lacombe, Andrea Tomasini and Arno W.R. van Kuijk have nothing to disclose. Laura Harrington is an employee of Ogilvy Health. Phillip S. Helliwell has received speaker fees from Novartis and participated in an advisory board for Amgen. Andrew Pothecary has received honoraria for lectures and educational events from AbbVie and Galapagos, for lectures and advisory boards from UCB Pharma and for advisory boards from Vifor Pharma and Thornton & Ross Ltd. Andrew Pothecary has also previously undertaken an unpaid volunteer position as an Expert Advisor at National Rheumatoid Arthritis Society (UK).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This manuscript is formed of the opinions of the authors themselves. There was no need to collect any type of patient data. Therefore, the approval of an ethics committee was not required. Consent was obtained from all participants (or stakeholders).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}